There are 2789 resources available
94P - ESCAT ranking of genomic alterations collected in the Italian Registry of Actionable Mutations
Presenter: Riziero Esposito Abate
Session: ePoster Display
95P - Optimizing selection of experimental treatment for patients with advanced cancer using whole genome sequencing
Presenter: Melinda Pruis
Session: ePoster Display
96P - Real-world single institution clinical outcome study of the impact of comprehensive genomic profiling (CGP) on targeted therapy selection and cancer patient survival
Presenter: Bhaskara Reddy Madhira
Session: ePoster Display
97P - Comparative serum metabolome analysis as a diagnostic tool in concomitant rheumatic and malignant diseases
Presenter: Dorothea Marx
Session: ePoster Display
98P - A stable NGS method to detect microsatellite instability status across different batches, sequencing platforms and cancer types
Presenter: Chenghong Lin
Session: ePoster Display
99P - The differentially fragmented regions in cell-free DNA of colorectal cancer patients
Presenter: Dmitry Shcherbo
Session: ePoster Display
100P - Characteristics and outcomes of patients (pts) with NTRK fusion-positive (NTRK+) metastatic / locally advanced (LA) solid tumours receiving non-TRK inhibitor (TRKi) standard of care (SoC), and prognostic value of NTRK fusions in clinical practice
Presenter: George Demetri
Session: ePoster Display
8P - The characterization of tumors associated with the antitumor activity of lenvatinib plus anti-PD-1 antibody combination therapy in a mouse syngeneic model panel
Presenter: Yoichi Ozawa
Session: ePoster Display
9P - Click Activated Protodrugs Against Cancer (CAPAC) platform enhances the safety, pharmacokinetics, and antitumor efficacy of cancer therapies in vivo
Presenter: Sangeetha Srinivasan
Session: ePoster Display
10P - DS-6000a, a novel CDH6-targeting antibody-drug conjugate with a novel DNA topoisomerase I inhibitor DXd, demonstrates potent antitumor activity in preclinical models
Presenter: Hirokazu Suzuki
Session: ePoster Display